메뉴 건너뛰기




Volumn 9, Issue 9, 2014, Pages

Treatment evolution after COPD diagnosis in the UK primary care setting

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT;

EID: 84910053236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105296     Document Type: Article
Times cited : (53)

References (16)
  • 2
    • 84869080591 scopus 로고    scopus 로고
    • Available: Accessed 2013 Jul 26
    • National Institute for Health and Clinical Excellence.NICE clinical guideline 101. Available: http://www.nice.org.uk/nicemedia/live/13029/49397/ 49397.pdf. Accessed 2013 Jul 26.
    • NICE Clinical Guideline 101
  • 4
    • 31544465514 scopus 로고    scopus 로고
    • International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Chronic Obstructive Pulmonary Disease (COPD)
    • DOI 10.1016/j.pcrj.2005.11.003, PII S1471441805001672, The International Primary Care Respiratory Group (IPCRG) Guidelines for the Management of Chronic Respiratoty Diseases
    • Bellamy D, Bouchard J, Henrichsen S, Johansson G, Langhammer A, et al. (2006) International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD). Prim Care Respir J 15: 48-57. (Pubitemid 43155766)
    • (2006) Primary Care Respiratory Journal , vol.15 , Issue.1 , pp. 48-57
    • Bellamy, D.1    Bouchard, J.2    Henrichsen, S.3    Johansson, G.4    Langhammer, A.5    Reid, J.6    Van Weel, C.7    Buist, S.8
  • 5
    • 0034988166 scopus 로고    scopus 로고
    • Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease
    • Martin J, Carrizo S, Gascon M, Sanchez A, Gallego B, et al. (2001) Inspiratory Capacity, Dynamic Hyperinflation, Breathlessness, and Exercise Performance during the 6-Minute-Walk Test in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 163: 1395-1399. (Pubitemid 32506605)
    • (2001) American Journal of Respiratory and Critical Care Medicine , vol.163 , Issue.6 , pp. 1395-1399
    • Marin, J.M.1    Carrizo, S.J.2    Gascon, M.3    Sanchez, A.4    Gallego, B.5    Celli, B.R.6
  • 6
    • 84871253503 scopus 로고    scopus 로고
    • The role of bronchodilator treatment in the prevention of exacerbations of COPD
    • Wedzicha J, Decramer M, Seemungal T (2012) The role of bronchodilator treatment in the prevention of exacerbations of COPD. Eur Respir J 40: 1545-1554.
    • (2012) Eur Respir J , vol.40 , pp. 1545-1554
    • Wedzicha, J.1    Decramer, M.2    Seemungal, T.3
  • 7
    • 85027923918 scopus 로고    scopus 로고
    • Beyond lung function in COPD management: Effectiveness of LABA/LAMA combination therapy on patient-centred outcomes
    • van der Molen T, Cazzola M (2012) Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes. Prim Care Respir J 21: 101-108.
    • (2012) Prim Care Respir J , vol.21 , pp. 101-108
    • Van Der Molen, T.1    Cazzola, M.2
  • 8
    • 20544450400 scopus 로고    scopus 로고
    • American Thoracic Society/European Respiratory Society. Available: Accessed 2013 Nov 22
    • American Thoracic Society/European Respiratory Society. Standards for diagnosis and management of patients with COPD. Available: http://www.thoracic. org/clinical/copd-guidelines/resources/copddoc.pdf. Accessed 2013 Nov 22.
    • Standards for Diagnosis and Management of Patients with COPD
  • 9
    • 84877712372 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease - A treatable disease
    • Osthoff M, Jenkins C, Leuppi JD (2013) Chronic obstructive pulmonary disease - a treatable disease. Swiss Med Wkly 143:0.
    • (2013) Swiss Med Wkly , vol.143 , pp. 0
    • Osthoff, M.1    Jenkins, C.2    Leuppi, J.D.3
  • 11
    • 80955169343 scopus 로고    scopus 로고
    • General practitioner's adherence to the COPD GOLD guidelines: Baseline data of the Swiss COPD Cohort Study
    • April 21
    • Jochmann A, Neubauer F, Miedinger D, Schafroth S, Tamm M, et al. (2010) General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly; April 21.
    • (2010) Swiss Med Wkly
    • Jochmann, A.1    Neubauer, F.2    Miedinger, D.3    Schafroth, S.4    Tamm, M.5
  • 13
    • 84946177942 scopus 로고    scopus 로고
    • Available: Accessed 2012 Oct 15
    • Clinical Practice Research Datalink. Available: http://www.cprd.com/home/ . Accessed 2012 Oct 15.
  • 14
    • 76849092094 scopus 로고    scopus 로고
    • Adaptation and validation of the Charlson Index for Read/OXMIS coded databases
    • Khan NF, Perera R, Harper S, Rose PW (2010) Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 11:1.
    • (2010) BMC Fam Pract , vol.11 , pp. 1
    • Khan, N.F.1    Perera, R.2    Harper, S.3    Rose, P.W.4
  • 15
    • 34047260228 scopus 로고    scopus 로고
    • Treatment persistence and compliance with medications for chronic obstructive pulmonary disease
    • Cramer JA, Bradley-Kennedy C, Scalera A (2007) Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 14: 25-29. (Pubitemid 46637657)
    • (2007) Canadian Respiratory Journal , vol.14 , Issue.1 , pp. 25-29
    • Cramer, J.A.1    Bradley-Kennedy, C.2    Scalera, A.3
  • 16
    • 0035832571 scopus 로고    scopus 로고
    • A survey of validity and utility of electronic patient records in a general practice
    • Hassey A, Gerrett D, Wilson A (2001) A survey of validity and utility of electronic patient records in a general practice. BMJ 322: 1401-1405. (Pubitemid 32523297)
    • (2001) British Medical Journal , vol.322 , Issue.7299 , pp. 1401-1405
    • Hassey, A.1    Gerrett, D.2    Wilson, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.